Journal
MOLECULAR THERAPY
Volume 11, Issue 4, Pages 523-530Publisher
CELL PRESS
DOI: 10.1016/j.ymthe.2004.12.019
Keywords
-
Categories
Funding
- NCI NIH HHS [R01 CA077340, R01 CA77340] Funding Source: Medline
- NHLBI NIH HHS [P01 HL066973, P01 HL051818] Funding Source: Medline
- NIDDK NIH HHS [R01 DK084033] Funding Source: Medline
- NIGMS NIH HHS [P01 GM 59299, P01 GM059299] Funding Source: Medline
Ask authors/readers for more resources
Small interfering RNAs (siRNAs) are potentially powerful tools for therapeutic gene regulation. DNA cassettes encoding RNA polymerase III promoter-driven hairpin siRNAs allow long-term expression of siRNA in targeted cells. A variety of viral vectors have been used to deliver such cassettes to cells. Here we report on the development and use of a self-complementary recombinant adeno-associated virus (scAAV) vector for siRNA delivery into mammalian cells. We demonstrate that this modified vector efficiently delivers siRNA into multidrug-resistant human breast and oral cancer cells and suppresses MDR1 gene expression. This results in rapid, profound, and durable reduction in the expression of the P-glycoprotein multidrug transporter and a substantial reversion of the drug-resistant phenotype. This research suggests that scAAV-based vectors can be very effective agents for efficient delivery of therapeutic siRNA.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available